The university marked a 10-year high for spinout generation and revealed its portfolio had cumulatively lured $452m in funding.

Bristol Myers Squibb, Eli Lilly and Novo are among the limited partners in the pharmaceutical-focused venture firm's BGV IV fund, which has reached its final close.

Novo helped the cardiac pump developer CorWave secure series C funding to increase its total funding to over $95m.

Diane Roujou de Boubée had previously held a manager position at corporate venture capital vehicle Sodexo Ventures.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Oxford Immunotec is set to return to private ownership in a $591m acquisition deal.

Existing investor Pasteur Mutualité came back for a round that will precede a trial of Volta's software, which helps in the treatment of cardiac arrythmias.

Discovery has provided about a third of the $81.7m closed by GB News as it prepares to launch its right-wing current affairs channel later this year.

The autonomous driving software provider completed a series B round led by BP Ventures that also featured corporate investors Tencent and Halma.